EcoDrugPlus

Erb-B2 Receptor Tyrosine Kinase 4

Ensembl ID : ENSAPOG00000011865
Gene Symbol: ERBB4
4 Cross references
211 Possible Orthologues:

Estrogen Receptor Beta-Like

Ensembl ID : ENSAPOG00000016564
Gene Symbol: LOC110970468
3 Cross references
197 Possible Orthologues:

Estrogen Receptor Beta-Like

Ensembl ID : ENSAPOG00000017834
Gene Symbol: LOC110956076
3 Cross references
199 Possible Orthologues:

Estrogen Receptor Beta-Like

Ensembl ID : ENSAPOG00000015965
Gene Symbol: LOC110949698
3 Cross references
207 Possible Orthologues:

Estrogen Receptor-Like

Ensembl ID : ENSAPOG00000008603
Gene Symbol: LOC110953976
3 Cross references
215 Possible Orthologues:

Estrogen Related Receptor Gamma

Ensembl ID : ENSAPOG00000008182
Gene Symbol: ESRRG
3 Cross references
203 Possible Orthologues:

Exportin 1

Ensembl ID : ENSAPOG00000004984
Gene Symbol: XPO1
3 Cross references
217 Possible Orthologues:

Exportin 1

Ensembl ID : ENSAPOG00000002354
Gene Symbol: XPO1
3 Cross references
228 Possible Orthologues:

Farnesyl Diphosphate Synthase

Ensembl ID : ENSAPOG00000021832
Gene Symbol: FDPS
3 Cross references
269 Possible Orthologues:

Farnesyl-Diphosphate Farnesyltransferase 1

Ensembl ID : ENSAPOG00000004074
Gene Symbol: FDFT1
3 Cross references
221 Possible Orthologues:

Farnesyltransferase, Caax Box, Alpha

Ensembl ID : ENSAPOG00000008573
Gene Symbol: FNTA
3 Cross references
222 Possible Orthologues:

Fibroblast Growth Factor Receptor 1

Ensembl ID : ENSAPOG00000010367
Gene Symbol: FGFR1
3 Cross references
201 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).